Probiotics are consistently among the top 5 most popular categories of dietary supplements. US sales of probiotic products are expected to reach nearly $500 million this year, and could top $2.6 billion by mid-decade, according to Statista.
There is good evidence that carefully selected probiotics offer myriad benefits for gastrointestinal as well as broader systemic health. However, there’s also a lot of hype.
How can you help your patients determine which strains will most likely deliver on their promise?
Join Dr. Reuben Wong, associate professor of medicine at the National University of Singapore for an in-depth research review of the latest studies on probiotics in the treatment of specific gastrointestinal disorders.
Dr. Wong, a practicing gastroenterologist and hepatologist, will help you distinguish the hope from the hype, with a deep dive into the evidence for specific probiotic strains, and their roles in supporting and restoring gut health.
How can you help your patients determine which strains will most likely deliver on their promise?
Learning Objectives:
• How probiotics can be applied to optimize gut health
• Gain insight into how patients and practitioners differ in their perception of digestive disorders
• Catch up on the latest evidence for the use of probiotics for different digestive disorders
• Review the data on specific probiotic strains in the context of digestive disease care
• Learn practical strategies and clinical pearls on how to use probiotics for gut health
This webinar is sponsored by HOWARU® probiotics, a DuPont™ Danisco® ingredient brand.
HOWARU® premium probiotic strains power probiotic brands that are focused on efficacy and quality. With more than 100 years of probiotic development and manufacturing experience, our scientists have studied thousands of strains, and selected strains with clinically demonstrated benefits to be designated as HOWARU®.
HOWARU® Single strains and pre-formulated blends have been studied under Good Clinical Practice guidelines to ensure the highest scientific and ethical standards and appear in leading peer-reviewed publications and evidence-based guidelines. When you recommend probiotics check to see if the brand you are recommending contains HOWARU® probiotic strains. Feel free to check out the website www.HOWARU.com/HCP to learn more about HOWARU® strain clinical data and commitment to quality. Check in periodically to review the latest scientific information on probiotics from the world leading manufacturers of probiotic strains.
In registering for this webinar, I acknowledge that I would like to receive email communications from DuPont Nutrition & Biosciences. I agree to the DuPont Privacy Policy, and to DuPont Nutrition & Biosciences getting in contact with me.
DuPont cares about your privacy. Your personal information (name, email, phone number and other contact data) will be stored in systems primarily hosted in the United States. This information will be used by DuPont, its affiliates, partners, and selected service providers in other countries to provide you with product or service information requested. DuPont does not sell your personal information to third parties. To learn more, please visit our Privacy Statement at https://www.dupont.com/privacy.html
Reuben Kong Min Wong , MBBS AGAF FRCP FAMS, is an Associate Professor of Medicine, and adjunct faculty at the National Univeristy of Singapore. Apart from being a practising specialist in Gastroenterology & Hepatology, he is also a Fellow of the American Gastroeneterological Assocation, Royal College of Physicians and Academy of Medicine (Singapore).
Dr. Wong completed his sub-specialty training at the University of North Carolina Chapel Hill under the mentorship of Professors Douglas Drossman and William Whitehead of the Rome Foundation. He honed his skills in the management of complex functional gastrointestinal disorders within a multi-disciplinary setting, and trained in esophageal motility and anorectal manometry testing.
In his 18 years of public service, he has authored key publications in the field of IBS, chronic constipation and gut motility, as well as being recognised for his work on quality improvement in colon cancer screening. He was part of the Rome Global Study workgroup, and lectures with the International Scientific Association for Probiotics and Prebiotics. He has an acive interest in the realm of gut microbiota, and was part of the team that introduced Fecal Microbiota Transplantation to Singapore.
Reuben is a founding partner of gutCARE, where his clinical practice is based. He’s actively involved in church and community service, and enjoys time with his wife Jane and their four kids.
